Tommy Law - Feb 16, 2023 Form 3 Insider Report for NovaBay Pharmaceuticals, Inc. (NBY)

Role
Interim CFO
Signature
/s/ Tommy Law
Stock symbol
NBY
Transactions as of
Feb 16, 2023
Transactions value $
$0
Form type
3
Date filed
2/24/2023, 03:45 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NBY Common Stock 0 Feb 16, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NBY Stock Option (right to buy) Feb 16, 2023 Common Stock 143 $31.15 Direct F1
holding NBY Stock Option (right to buy) Feb 16, 2023 Common Stock 715 $34.65 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option grant will vest over four years, with 25% vesting on the first anniversary of the grant date and 6.25% vesting very three months thereafter.